Reference health
Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
131/131 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
22 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 131 checked references that resolve
resolves10.1080/10496475.2011.602471
Biotechnology and Pharmacological Evaluation of Medicinal Plants: An Overview
resolves10.1021/ar500427k
The Quest for a Practical Synthesis of Morphine Alkaloids and Their Derivatives by Chemoenzymatic Methods
resolves10.1155/2015/796349
Optimization of Ultrasound-Assisted Extraction of Morphine from Capsules of<i>Papaver somniferum</i>by Response Surface Methodology
resolves10.1016/j.ejmech.2019.02.076
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
resolves10.2174/138945011793591626
Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
resolves10.1016/j.quaint.2009.11.002
Early Holocene coastal environment change inferred from deposits at Okinoshima archeological site, Boso Peninsula, central Japan
resolves10.1016/j.jep.2006.05.034
A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China
resolves10.1177/0967772015596276
Sir William Brooke O’Shaughnessy (1808–1889), MD, FRS, LRCS Ed: Chemical pathologist, pharmacologist and pioneer in electric telegraphy
resolves10.1002/cbdv.200790144
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
resolves10.1021/ja01062a046
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
resolves10.2174/1570159X17666190903103923
The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
resolves10.3390/molecules24173031
Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity
resolves10.1016/j.biopsych.2016.01.004
Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
resolves10.1016/S2215-0366(14)00117-5
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
resolves10.3389/fpsyt.2013.00130
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
resolves10.1038/npp.2009.184
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
resolves10.5507/bp.2018.007
Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice
resolves10.3390/brainsci9010014
Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products
resolves10.1016/j.jpainsymman.2016.09.003
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report
resolves10.3390/molecules23071526
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
resolves10.1016/j.lfs.2005.09.011
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
resolves10.1371/journal.pone.0201119
Accumulation of bioactive metabolites in cultivated medical Cannabis
resolves10.1016/j.ejim.2018.01.001
Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
resolves10.1089/can.2018.0039
<i>Cannabis</i>
Systematics at the Levels of Family, Genus, and Species
resolves10.3390/biom10050758
Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602
resolves10.1038/npp.2017.209
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
resolves10.1016/j.pharmthera.2017.02.041
Cannabidiol: State of the art and new challenges for therapeutic applications
resolves10.1002/jcph.1387
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
resolves10.1016/j.phrs.2017.05.005
Cannabidiol in medical marijuana: Research vistas and potential opportunities
resolves10.2147/DHPS.S158592
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
resolves10.1021/ja01253a008
Isolation of a Physiologically Active Tetrahydrocannabinol from Cannabis Sativa Resin
resolves10.1089/can.2016.0040
Identification of Terpenoid Chemotypes Among High (−)-
<i>trans</i>
-Δ
<sup>9</sup>
- Tetrahydrocannabinol-Producing
<i>Cannabis sativa</i>
L. Cultivars
resolves10.1089/can.2015.0012
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
resolves10.1007/s13311-014-0304-z
Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
resolves10.1021/acs.jnatprod.5b00949
Evolution of the Cannabinoid and Terpene Content during the Growth of <i>Cannabis sativa</i> Plants from Different Chemotypes
resolves10.3390/ijms19071992
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
resolves10.1021/ja01858a058
Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I
resolves10.1039/c29700000273
A new type of cannabinoid. Synthesis of cannabielsoic acid A by a novel photo-oxidative cyclisation
resolves10.1248/bpb.b13-00183
Structural Requirements for Potent Direct Inhibition of Human Cytochrome P450 1A1 by Cannabidiol: Role of Pentylresorcinol Moiety
resolves10.1016/0031-9422(77)80023-X
Cannabinodiol: Conclusive identification and synthesis of a new cannabinoid from Cannabis sativa
resolves10.1089/can.2016.0017
Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification
resolves10.3390/molecules23102639
New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)
resolves10.1016/0040-4039(80)80248-6
Extractives of Thailand cannabis: Synthesis of canniprene and isolation of new geranylated and prenylated chrysoeriols
resolves10.1016/0006-2952(85)90325-9
Isolation from cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production
resolves10.1139/b05-030
A forty-year journey in plant research: original contributions to flavonoid biochemistry
resolves10.1016/S0031-9422(00)98242-6
Cannabisin A, an arylnaphthalene lignanamide from fruits of Cannabis sativa
resolves10.1021/acs.jafc.5b05282
Characterization of Lignanamides from Hemp (<i>Cannabis sativa</i> L.) Seed and Their Antioxidant and Acetylcholinesterase Inhibitory Activities
resolves10.3390/ijms20030507
Cannabisin F from Hemp (Cannabis sativa) Seed Suppresses Lipopolysaccharide-Induced Inflammatory Responses in BV2 Microglia as SIRT1 Modulator
resolves10.1016/j.foodchem.2012.03.133
Content, composition, and stereochemical characterisation of lignans in berries and seeds
resolves10.1039/C8FO01896K
Stilbenoids and cannabinoids from the leaves of
<i>Cannabis sativa f. sativa</i>
with potential reverse cholesterol transport activity
resolves10.5424/sjar/2010082-1220
Fatty acid composition of hempseed oils from different locations in Turkey
resolves10.1186/s13643-018-0761-2
Cannabis for pediatric epilepsy: protocol for a living systematic review
resolves10.12688/f1000research.16515.1
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects
resolves10.1056/NEJMoa1611618
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
resolves10.1016/S0140-6736(18)30136-3
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
resolves10.1016/j.pneurobio.2017.10.007
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
resolves10.2174/1570159X14666161101095325
Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
resolves10.1186/s13722-015-0032-7
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
resolves10.1007/s00520-020-05310-6
Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults
resolves10.1007/s00280-017-3387-5
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
resolves10.1177/2058738419838383
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
resolves10.3390/medicines5030067
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
resolves10.21037/apm.2018.05.08
A hunger for hunger: a review of palliative therapies for cancer-associated anorexia
resolves10.1007/s00105-005-1063-x
Dronabinol zur supportiven Therapie metastasierter maligner Melanome mit Lebermetastasen
resolves10.1080/17474124.2017.1292851
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
resolves10.1097/01.MIB.0000440982.79036.d6
Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
resolves10.1016/j.cgh.2013.04.034
Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
resolves10.1097/WNF.0000000000000016
Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease
resolves10.3390/brainsci7050047
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
resolves10.1167/iovs.16-20757
Development of a Δ
<sup>9</sup>
-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
resolves10.5005/jp-journals-10008-1161
Complementary and Alternate Management of Glaucoma: The Verdict so Far
resolves10.1080/17476348.2020.1787836
Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients
resolves10.3389/fimmu.2020.01708
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
resolves10.3390/ijms21113809
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
resolves10.1007/s00228-020-02963-4
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
resolves10.1016/j.bbi.2020.04.079
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
resolves10.1089/can.2020.0043
Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA
resolves10.1016/j.bcp.2008.06.022
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
resolves10.1128/mSphere.00288-20
Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
resolves10.1089/acm.2020.0144
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence
The 22 references without a DOI — listed, not checked
no DOI — not checkedConstitution of codeine and thebaine
no DOI — not checkedSilverstein, A.M. (2001). Paul Ehrlich’s Receptor Immunology: The Magnificent Obsession, Elsevier.
no DOI — not checkedCombination therapy in the treatment of hypertension
no DOI — not checkedCannabinoids for pediatric epilepsy? Up in smoke or real science?
no DOI — not checkedIsolace dalsˇích látek z listí indického konopí Cannabis sativa L.
no DOI — not checkedNotes on the structure of cannabidiol compounds
no DOI — not checkedDrugs, U.N.O. (2009). Crime Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products: Manual for Use by National Drug Testing Laboratories, United Nations Publications.
no DOI — not checkedCannabichromene, a new active principle in hashish
no DOI — not checkedConstituents of hemp plant (Cannabis sativa). III. Isolation of a Gibbs-positive compound from Japanese hemp
no DOI — not checkedCannabinoids and terpenes as chemotaxonomic markers in cannabis
no DOI — not checkedNMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa
no DOI — not checkedHemp seed oil: A source of valuable essential fatty acids
no DOI — not checkedPate, D.W. (1999). Hemp seed: A valuable food source. Adv. Hemp Res., 243–255.
no DOI — not checkedThe essential fatty acids omega-6 and omega-3: From their discovery to their use in therapy
no DOI — not checkedDronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
no DOI — not checkedNarain, T., and Farrah, K. (2017). Nabilone for Non-Chemotherapy Associated Nausea and Vomiting and Weight Loss Due to Medical Conditions: A Review of Clinical Effectiveness and Guidelines, Canadian Agency for Drugs and Technologies in Health.
no DOI — not checkedFocus: Addiction: US Policy Responses to Calls for the Medical Use of Cannabis
no DOI — not checkedMarijuana compounds: A nonconventional approach to Parkinson’s disease therapy
no DOI — not checkedAbramovici, H. (2018). Information for Health Care Professionals: Cannabis (Marihuana, Marijuana) and the Cannabinoids, Health Canada.
no DOI — not checkedFocus: Addiction: Marijuana for Glaucoma: A Recipe for Disaster or Treatment?
no DOI — not checkedThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status
no DOI — not checkedCascella, M., Rajnik, M., Cuomo, A., Dulebohn, S.C., and Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). Statpearls [Internet], StatPearls Publishing.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3390/ijms22020778"><img src="https://citestamp.com/citestamped/10.3390/ijms22020778/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3390/ijms22020778)